Relative to its peers, MESO does not have very much institutional sponsorship. The 3.08% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRINCETON CAPITAL MANAGEMENT, IN... Bought 37.8 Thousand shares of Mesoblast Ltd